We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Breast Implants Linked to Lung, Brain Cancers

By HospiMedica staff writers
Posted on 09 May 2001
A long-term study has found that women with breast implants seem to have higher rates of brain and lung cancer compared to other plastic surgery patients. More...
The researchers, from the U.S. National Cancer Institute (NIH, Bethesda, MD), stress that their findings do not show a direct cause-and-effect relationship but only a link whose significance is unclear. The study was reported in the May issues of two medical journals, Annals of Epidemiology and Epidemiology.

More than 13,000 women with breast implants received prior to 1989 were followed by the researchers for around 13 years and were compared with 4,000 women with other types of plastic surgery and with the general population. The results focused on the plastic surgery group, based on questionnaires returned by 7,500 women and on medical records. Most of the women had silicone implants, which were removed from the market in 1992. Only about 10% of the women had saline implants.

The results showed that women with implants of either type had a threefold risk of dying of respiratory tract diseases, primarily lung cancer, compared to women in the general plastic surgery control group. They also had a higher rate of dying from pneumonia and emphysema and had a twofold risk of dying of brain cancer. In trying to understand the high incidence of brain cancer, the researchers noted the many neurologic alterations noted by women with implants, including memory loss and cognitive dysfunction, and concluded that implants might have been more directly involved than previously thought. According to the lead author, Dr. Louise A. Brinton, chief of the environmental epidemiology branch of the NCI, smoking could not be ruled out as a factor. Since no plausible explanation could be found for the brain cancer finding, further research is needed, say the investigators.

Several years ago, a panel of scientists assembled by the U.S. Institute of Medicine reviewed the medical literature pertaining to silicone implants and reached the conclusion that the implants were not associated with any major disease. Recently, a study published in the May issue of Plastic and Reconstructive Surgery found no evidence to support a link between breast implants and cancer, based only on an analysis of scientific literature.



Related Links:
U.S. National Cancer Institute

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.